FDA Approves Sun Pharma's Benzonatate Capsules
Posted on: Monday, 24 March 2008, 09:01 CDT
Sun Pharmaceutical Industries has announced that the FDA has granted approval for the abbreviated new drug application to market benzonatate capsules.
Benzonatate USP capsules are therapeutically equivalent to Forest Lab's Tessalon, and are available in two strengths: capsules containing 100mg and 200mg benzonatate USP.
Benzonatate is an antitussive, used to relieve cough due to the common cold, bronchitis, pneumonia, or other lung infections. This product will reach market shortly.
Source: Datamonitor
Related Articles
- ETHEX Corporation Issues Nationwide Voluntary Recall of Products
- Lu Returns to Earth in Soyuz Capsule
- Chinese greet arrival of space capsule
- Chinese Astronaut OK; Capsule Gets Checkup
- China Studies Returned Space Capsule
- Wash. H.S. Time Capsule Disintegrates
- India plans to launch recoverable spacecraft capsule
- Japan Successfully Retrieves Space Capsule
- 'Fruit Capsule' May Lessen Artery Damage
Rating: 3.9 / 5 (8 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds